Therefore, ADAMTS9‐AS2 functions as a novel tumour suppressor in glioma, and DNMT1 plays a regulatory role in modulating ADAMTS9‐AS2 [108]. This evidence concerns the gene ADAMTS9 and central nervous system cancer.